Esteban Santos - 02 May 2023 Form 4 Insider Report for AMGEN INC (AMGN)

Role: EVP, Operations
Signature: /s/ Esteban Santos
Issuer symbol: AMGN
Transactions as of: 02 May 2023
Net transactions value: -$168,955
Form type: 4
Filing time: 04 May 2023, 20:33:33 UTC
Previous filing: 02 May 2023
Next filing: 09 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Award	$0	+3,559	+5.8%	$0.000000	64,877	02 May 2023	Direct	F1
transaction	AMGN	Common Stock	Tax liability	$168,955	-716	-1.1%	$235.97	64,161	03 May 2023	Direct	F2, F3
holding	AMGN	Common Stock						828	02 May 2023	401K Plan	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMGN	Nqso (Right to Buy)	Award	$0	+30,100		$0.000000	30,100	02 May 2023	Common Stock	30,100	$235.97	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively.
F2	These shares include the following RSUs granted under the Company's equity plans: 2,268 RSUs which will vest in installments of 1,117 on 5/5/2023 and 1,151 on 5/5/2024; 2,656 RSUs which will vest in installments of 1,308 on 4/30/2024 and 1,348 on 4/30/2025; 3,637 RSUs which will vest in two installments of 1,200 on 5/2/2024 and on 5/2/2025, and one installment of 1,237 on 5/2/2026; and 3,559 RSUs which vest in two installments of 1,174 on 5/2/2025 and 5/2/2026, and 1,211 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3	These shares include 512 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4	These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
F5	These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively.